1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI : An Analysis Based on the GOLD Randomized Trial (GOLD 8)
(
- Contribution to journal › Article
- 2023
-
Mark
Glycemic control and outcome after carotid intervention in patients with T2D : A Swedish nationwide cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes : an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry
(
- Contribution to journal › Article
-
Mark
Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention : a Swedish nationwide propensity score matched cohort study
(
- Contribution to journal › Article
-
Mark
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring : An analysis based on the GOLD randomized trial (GOLD-5)
(
- Contribution to journal › Article
- 2020
-
Mark
The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke : A prospective study of 418 329 participants in the EPIC cohort across nine European countries
(
- Contribution to journal › Article
- 2019
-
Mark
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
(
- Contribution to journal › Article
- 2018
-
Mark
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
(
- Contribution to journal › Article
- 2017
-
Mark
Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections the gold randomized clinical trial
(
- Contribution to journal › Article
- 2015
-
Mark
Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
(
- Contribution to journal › Article